CKD Clinical Trials

13 recruiting

CKD Trials at a Glance

56 actively recruiting trials for ckd are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 18 trials, with the heaviest enrollment activity in Herlev, Taipei, and Birmingham. Lead sponsors running ckd studies include National Taiwan University Hospital, Hacettepe University, and Grigore T. Popa University of Medicine and Pharmacy.

Browse ckd trials by phase

Treatments under study

About CKD Clinical Trials

Looking for clinical trials for CKD? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new CKD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about CKD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 56 trials

Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

CKDMetabolic Acidosis
Renibus Therapeutics, Inc.150 enrolled16 locationsNCT07355062
Recruiting
Phase 2

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

Heart FailureCardiovascular DiseasesCKD
University Medical Center Groningen100 enrolled2 locationsNCT07304817
Recruiting

Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)

Rate of CKD Diagnosis in Patients With AH and CKD MarkersDemographic and Clinical Characteristics for Those PatientsRoutine Therapy Before and After the Diagnosis of CKD
AstraZeneca1,282 enrolled29 locationsNCT06744335
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University750 enrolled6 locationsNCT06906627
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University420 enrolled6 locationsNCT06906640
Recruiting
Phase 1

A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Regend Therapeutics15 enrolled1 locationNCT07275788
Recruiting
Not Applicable

Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

CKDMalnutrition (Calorie)Low Protein Dietary Intake
Fresenius Kabi Taiwan Ltd.80 enrolled3 locationsNCT06892249
Recruiting
Phase 2

Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis

CKD (Chronic Kidney Disease) Stage 5DESRD
McGill University Health Centre/Research Institute of the McGill University Health Centre30 enrolled1 locationNCT06913647
Recruiting
Not Applicable

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease

Chronic Kidney Disease(CKD)
University of Illinois at Chicago40 enrolled1 locationNCT06754280
Recruiting
Not Applicable

The Effects of Dietary Nitrate in Patients With Hypertensive Kidney Injury

HypertensionCKD - Chronic Kidney Disease
Gødstrup Hospital20 enrolled1 locationNCT07290842
Recruiting

The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations

CKD
University of Copenhagen50 enrolled2 locationsNCT07312981
Recruiting
Not Applicable

Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery

NephrectomyKidney TumorsCKD+1 more
Jinling Hospital, China200 enrolled1 locationNCT07062952
Recruiting
Phase 2

Canagliflozin in Advanced Renal Disease With MRI Endpoints

ESRD, CKD Stage 4, CKD Stage 5
McGill University Health Centre/Research Institute of the McGill University Health Centre92 enrolled1 locationNCT06182839
Recruiting
Not Applicable

Studies on Adsorption International Learning Initiative Global

HemodialysisCKD (Chronic Kidney Disease) Stage 5DInflammation Biomarkers+5 more
Botkin Hospital60 enrolled1 locationNCT07123909
Recruiting

MEMRI and Kidney Disease

Kidney TransplantAcute Kidney InjuryVasculitis+1 more
University of Edinburgh120 enrolled1 locationNCT06698614
Recruiting
Phase 3

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Chronic Kidney Disease(CKD)Uncontrolled Hypertension
University Hospital, Tours720 enrolled40 locationsNCT05732727
Recruiting
Phase 4

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease

Chronic Kidney Disease(CKD)
Peter Rossing125 enrolled4 locationsNCT07239570
Recruiting

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

CKD - Chronic Kidney DiseaseHeart Failure Preserved Ejection Fraction
Grigore T. Popa University of Medicine and Pharmacy200 enrolled1 locationNCT07237451
Recruiting
Phase 4

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Heart FailureSarcopeniaOsteoporosis+11 more
Bettina Mittendorfer100 enrolled1 locationNCT07083557